Related Experiment Video
Updated: Jun 27, 2026

Surgical Angiogenesis in Porcine Tibial Allotransplantation: A New Large Animal Bone Vascularized Composite Allotransplantation Model
Published on: August 13, 2017
Periacetabular Resection for Bone Tumors: Is There Still a Role for Massive Allograft-prosthesis Composite
Roberto Scanferla1, Sreeraj Rajan2, Federico Scolari1
1Department of Orthopaedic Oncology and Reconstructive Surgery, Careggi University Hospital, Florence, Italy.
Allograft-prosthesis composite reconstruction for periacetabular tumors shows a 33% complication rate by 15 years, with a mean Musculoskeletal Tumor Society (MSTS) score of 23. This method remains effective for preserving bone stock and enabling future revisions.
Area of Science:
- Orthopedic oncology
- Reconstructive surgery
- Bone tumor treatment
Background:
- Allograft-prosthesis composite reconstruction offers bony union and preserves bone stock for revisions after periacetabular resections.
- Endoprosthetic reconstruction is common for periacetabular defects but compromises bone stock and has long manufacturing times.
- Few long-term results exist for allograft-prosthesis composite reconstruction in the pelvis following periacetabular resections for bone tumors.
Purpose of the Study:
- To determine the cumulative incidence of complications following allograft-prosthesis composite reconstruction for periacetabular tumors.
- To evaluate functional outcomes using the Musculoskeletal Tumor Society (MSTS) score at a minimum of 2 years post-surgery.
- To assess the 15-year survivorship of these reconstructions, free from revision or graft removal.
Main Methods:
- A retrospective study of 51 patients undergoing periacetabular resection and allograft-prosthesis composite reconstruction for pelvic bone tumors between 1994 and 2023.
- Analysis included 96% of patients with a minimum 24-month follow-up or earlier complications.
- Competing-risk methods were used to estimate cumulative incidence of major complications and graft removal; functional outcomes assessed via MSTS scores.
Main Results:
- The cumulative incidence of major complications reached 33% by 15 years post-reconstruction.
- The mean Musculoskeletal Tumor Society (MSTS) score was 23 ± 5, assessed approximately 10 years after surgery.
- The cumulative incidence of graft removal was 12% at 15 years.
Conclusions:
- Allograft-prosthesis composite reconstruction is an effective option for periacetabular resection, even with advancements in 3D-printed implants.
- This technique remains valuable for patients with long life expectancy, particularly when chemotherapy/radiotherapy are not primary treatments and the iliac wing is preserved.
- Further comparative studies are needed to evaluate allograft-prosthesis composites against other reconstructive methods like custom endoprostheses and recycled autografts.
Related Concept Videos
Bone Remodeling and Repair
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

